Corbenic Partners LLC Pulse Biosciences, Inc. Transaction History
Corbenic Partners LLC
- $380 Million
- Q2 2022
A detailed history of Corbenic Partners LLC transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Corbenic Partners LLC holds 65 shares of PLSE stock, worth $1,118. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65
Previous 65
-0.0%
Holding current value
$1,118
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PLSE
# of Institutions
60Shares Held
4.78MCall Options Held
138KPut Options Held
96.2K-
Black Rock Inc. New York, NY1.15MShares$19.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA905KShares$15.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC783KShares$13.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA424KShares$7.29 Million0.0% of portfolio
-
State Street Corp Boston, MA392KShares$6.74 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $639M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...